Bank Erin M, Small Eric J, Ashworth Alan, Hiatt Robert A
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, United States.
Prev Oncol Epidemiol. 2023;1(1):1-9. doi: 10.1080/28322134.2023.2265563. Epub 2023 Nov 17.
Following the successful renewal of its Cancer Center Support Grant (CCSG), leadership of the UCSF Helen Diller Comprehensive Cancer Center (HDFCCC) began a strategic planning process. The motivation was to think about where cancer research was going in the future; and with this vision to define a general scientific direction, mission, and priorities. HDFCCC Leadership began discussions about a new strategic plan in early 2018. From these meetings, the theme of "Cancer Research in 2030" arose: that is, what will cancer research look like in 2030? This forward-looking focus was intended to encourage creativity unconfined by a particular institutional structure or grant mechanism. Focusing on the science paved the way for an innovative, actionable, and motivating strategic planning process. Here, we describe the three-phase process, and the various groups involved across the HDFCCC and UCSF. We present the unique framework based on a cells-to-society model and an individual experience perspective, which led to the development of a logic model and ongoing implementation of tactics and tracking progress. We believe that sharing this process and its results will be of value to cancer centers and cancer researchers across the network of NCI comprehensive cancer centers, and cancer research centers in general.
在成功续签其癌症中心支持资助（CCSG）之后，加州大学旧金山分校海伦·迪勒综合癌症中心（HDFCCC）的领导层启动了一项战略规划进程。其动机是思考癌症研究未来的发展方向；并以此愿景来确定总体科学方向、使命和优先事项。HDFCCC领导层于2018年初开始讨论一项新的战略计划。从这些会议中，“2030年癌症研究”的主题应运而生：也就是说，2030年的癌症研究将会是什么样子？这种前瞻性的重点旨在鼓励不受特定机构结构或资助机制限制的创造力。专注于科学为创新、可行且具有激励性的战略规划进程铺平了道路。在此，我们描述这个三阶段过程，以及HDFCCC和加州大学旧金山分校涉及的各个团体。我们展示基于细胞到社会模型和个人经验视角的独特框架，该框架促成了逻辑模型的开发以及策略的持续实施和进展跟踪。我们相信，分享这个过程及其结果将对NCI综合癌症中心网络中的癌症中心和癌症研究人员以及一般的癌症研究中心有价值。
